Concepts (63)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 2 | 2022 | 907 | 0.230 |
Why?
|
| Dietary Fiber | 1 | 2021 | 123 | 0.200 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2018 | 8 | 0.170 |
Why?
|
| Glutathione Reductase | 1 | 2018 | 17 | 0.170 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2018 | 26 | 0.170 |
Why?
|
| Probiotics | 1 | 2021 | 228 | 0.170 |
Why?
|
| Synthetic Lethal Mutations | 1 | 2018 | 25 | 0.170 |
Why?
|
| Thioredoxins | 1 | 2018 | 50 | 0.160 |
Why?
|
| Neutropenia | 1 | 2022 | 968 | 0.160 |
Why?
|
| Interleukin-2 | 1 | 2020 | 842 | 0.150 |
Why?
|
| Polyethylene Glycols | 1 | 2020 | 615 | 0.150 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 7222 | 0.150 |
Why?
|
| Glutathione | 1 | 2018 | 368 | 0.140 |
Why?
|
| Osteosarcoma | 1 | 2020 | 929 | 0.110 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2019 | 5319 | 0.100 |
Why?
|
| Bone Neoplasms | 1 | 2020 | 2576 | 0.080 |
Why?
|
| Mice, Inbred NOD | 2 | 2019 | 905 | 0.070 |
Why?
|
| Mice, SCID | 2 | 2019 | 1869 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 6550 | 0.060 |
Why?
|
| Melanoma | 1 | 2021 | 5317 | 0.060 |
Why?
|
| Verrucomicrobia | 1 | 2022 | 26 | 0.060 |
Why?
|
| Propionates | 1 | 2022 | 71 | 0.060 |
Why?
|
| Lung Neoplasms | 3 | 2020 | 11538 | 0.050 |
Why?
|
| Mucus | 1 | 2022 | 119 | 0.050 |
Why?
|
| Fatty Acids, Volatile | 1 | 2021 | 52 | 0.050 |
Why?
|
| Mucins | 1 | 2022 | 285 | 0.050 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2021 | 149 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 7789 | 0.050 |
Why?
|
| Mice, Inbred C3H | 1 | 2020 | 385 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 3821 | 0.050 |
Why?
|
| Mice | 4 | 2022 | 34495 | 0.040 |
Why?
|
| Melanoma, Experimental | 1 | 2021 | 368 | 0.040 |
Why?
|
| Animals | 5 | 2022 | 59536 | 0.040 |
Why?
|
| Antigens, CD20 | 1 | 2019 | 206 | 0.040 |
Why?
|
| Auranofin | 1 | 2018 | 38 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 15862 | 0.040 |
Why?
|
| T-Lymphocytes | 2 | 2021 | 3869 | 0.040 |
Why?
|
| Feces | 1 | 2021 | 770 | 0.040 |
Why?
|
| Heterografts | 1 | 2019 | 733 | 0.040 |
Why?
|
| Antirheumatic Agents | 1 | 2018 | 167 | 0.040 |
Why?
|
| Neoplasms | 1 | 2022 | 15193 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 2314 | 0.030 |
Why?
|
| Diet | 1 | 2022 | 1440 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2020 | 1987 | 0.030 |
Why?
|
| Homeostasis | 1 | 2018 | 950 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 1294 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 1586 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 5395 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 6942 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2019 | 5710 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 6207 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2020 | 9180 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 9244 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2021 | 3341 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2018 | 7226 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 14551 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 5178 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 13658 | 0.010 |
Why?
|
| Humans | 4 | 2021 | 261506 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 8873 | 0.010 |
Why?
|
| Female | 2 | 2021 | 141928 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 32848 | 0.010 |
Why?
|
| Male | 1 | 2021 | 123000 | 0.010 |
Why?
|